5 Best Penny Stocks to Buy for Long Term

In this article, we will list the 5 Best Penny Stocks to Buy for Long Term. Please visit 10 Best Penny Stocks to Buy for Long Term if you would like to see the extended list and the methodology behind it.

5. Savara Inc. (NASDAQ:SVRA)

On May 12, 2026, Savara Inc. (NASDAQ:SVRA) reported Q1 EPS of (15c), versus the consensus estimate of (14c). Chair and CEO Matt Pauls said the company ended the quarter with approximately $203M in cash and expects to have access to as much as $150M in additional non-dilutive funding through debt and royalty financing structures if MOLBREEVI receives approval. Management said this positions the company to support global commercial launch activities. Pauls added that preparations ahead of the November 22 PDUFA date are accelerating, with the company’s Rare Disease Specialist team already focused on increasing awareness of autoimmune PAP and advancing launch readiness for MOLBREEVI, which could become the first approved treatment for the disease.

Last month, Oppenheimer analyst Mazahir Alimohamed assumed coverage of Savara Inc. (NASDAQ:SVRA) with an Outperform rating and raised the firm’s price target to $11 from $9. The firm said the company’s investment story is increasingly centered on regulatory execution and commercialization following the FDA’s Priority Review for the BLA submission of molgramostim, an inhaled GM-CSF therapy. Oppenheimer added that data from the Phase 3 IMPALA-2 study in autoimmune PAP support a high-probability approval outlook, noting that prior FDA feedback was primarily related to chemistry, manufacturing, and controls.

Savara Inc. (NASDAQ:SVRA) is a clinical-stage biopharmaceutical company focused on therapies for rare respiratory diseases.